Elite Pharmaceuticals (ELTP) Gross Profit (2010 - 2026)
Elite Pharmaceuticals (ELTP) recorded Gross Profit of $13.51 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 50.4% from $27.23 million a year earlier and down 35.0% from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) Gross Profit (2010 - 2026) Analysis & Trends
On a TTM basis, Elite Pharmaceuticals' Gross Profit came in at $61.31 million as of Jun 30, 2026, up 4.2% year-over-year; for FY2026 (ended Mar 31, 2026), it was $75.02 million, up 87.2% from FY2025.
- Annual Gross Profit has increased for seven straight fiscal years, with a five-year compound annual growth rate of 44.6% (FY2021 to FY2026).
- Across earlier fiscal years, Gross Profit came in at $40.09 million in FY2025 (+52.1%), $26.36 million in FY2024 (+58.8%), $16.59 million in FY2023 (+12.2%) and $14.8 million in FY2022 (+24.7%).
- Quarterly Gross Profit has ranged from $3.41 million in fiscal Q4 2022 to $27.23 million in fiscal Q1 2026 over the past five years.
- On a year-over-year basis, Gross Profit rose in six of the last eight quarters, with growth averaging 62.7%.
- Peak year-over-year performance for Gross Profit in the last five years was growth of 221.3% in fiscal Q1 2026, against a decline of 50.4% in fiscal Q1 2027 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $20.77 million (Q4 2026), $12.95 million (Q3 2026) and $14.07 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Elite Pharmaceuticals | 269.31 Mn | 150.98 Mn | 13.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.51 Mn |
| Mar 31, 2026 | 20.77 Mn |
| Dec 31, 2025 | 12.95 Mn |
| Sep 30, 2025 | 14.07 Mn |
| Jun 30, 2025 | 27.23 Mn |
| Mar 31, 2025 | 17.30 Mn |
| Dec 31, 2024 | 6.12 Mn |
| Sep 30, 2024 | 8.20 Mn |
| Jun 30, 2024 | 8.47 Mn |
| Mar 31, 2024 | 8.12 Mn |
| Dec 31, 2023 | 7.04 Mn |
| Sep 30, 2023 | 6.45 Mn |
| Jun 30, 2023 | 4.75 Mn |
| Mar 31, 2023 | 3.44 Mn |
| Dec 31, 2022 | 4.92 Mn |
| Sep 30, 2022 | 3.82 Mn |
| Jun 30, 2022 | 4.00 Mn |
| Mar 31, 2022 | 3.41 Mn |
| Dec 31, 2021 | 4.02 Mn |
| Sep 30, 2021 | 3.77 Mn |
API Access
Elite Pharmaceuticals Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();